Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Data waiving:
other justification
Justification for data waiving:
the study need not be conducted because (i) inhalation of the substance is likely and (ii) skin contact in production and/or use is not likely and (iii) the physicochemical and toxicological properties suggest no potential for a significant rate of absorption
Justification for type of information:
JUSTIFICATION FOR DATA WAIVING

Dermal toxicity is unlikely to result in a more severe classification than the corresponding oral hazard, therefore we can read across from the acute oral GHS classification and use the same classification for acute dermal toxicity.

Currently we can confirm that

• Acute oral toxicity is not classified.
• The 14 day repeat oral dose study shows no systemic effects.
• 28 day repeat dose NOAEL 1000mg/kg/day.
• High molecular weight confirms low permeability through the skin (greater than 500 MW)
• Partition coefficient value (Log Pow >6.5) also indicates low permeability through the skin

Based on the information listed above we can confirm dermal toxicity is unlikely and endpoint is considered as non hazardous.


Data source

Materials and methods

Results and discussion

Applicant's summary and conclusion